Leeds Industry Academy: Maximising Engagement with Industry
Lead Research Organisation:
University of Leeds
Department Name: UNLISTED
Abstract
Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.
Technical Summary
The MRC Proximity to Discovery scheme awards universities funds to help develop new collaborations, and ways of exchanging knowledge and skills. The awards can be used to support activities that promote the value of academic-industry partnership, and enhance academic and industry researchers’ understanding of each other’s needs and capabilities. This may be through people exchanges, creation of technology demonstrators, showcase events, commercialisation workshops and ‘entrepreneurs in residence’ schemes. Such exchanges of knowledge and skills will boost the most fruitful collaborations between UK universities and life science companies.
Organisations
People |
ORCID iD |
Publications
Murray LJ
(2017)
Pelvic re-irradiation using stereotactic ablative radiotherapy (SABR): A systematic review.
in Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
| Description | Applying Industry Standards to Academic Research |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | Local |
| Primary Audience | Postgraduate students |
| Results and Impact | Diane Wilkinson, former Fermentation Manager at Albumedix Ltd will be presenting on the importance of designing, implementing and executing academic research which is compatible to industry standards. Also included in her presentation was Good Manufacturing Practices and how industry works with academia. Outcomes: Whilst many academics are interested in certifying their labs to be GM compliant, concerns remain how this could be done in an academic environment with shared space and assets. |
| Year(s) Of Engagement Activity | 2018 |
| Description | Developing a new drug - the pathway towards successful translation |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | Regional |
| Primary Audience | Other audiences |
| Results and Impact | Peter Weissberg presented a seminar aimed to educate academics on how to go about successfully translating their discovery science into something that will attract investment. Peter then offered individual 1:1 non-confidential meetings with any investigators who have particular projects they would like some advice on. |
| Year(s) Of Engagement Activity | 2018 |
| Description | How Industry Works with Academics |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | Local |
| Primary Audience | Postgraduate students |
| Results and Impact | Lena Vukasinovic from Lena Biosciences gave a small informal presentation to discuss her research, how she transitioned from academia to industry and the strategies she now uses to work with Universities. Outcomes: The majority of attendees were early career researchers who found it interesting to hear first-hand experiences in working with University's and transitioning into academia |
| Year(s) Of Engagement Activity | 2018 |
| Description | MRC Translation Programmes Information Session |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | Regional |
| Primary Audience | Professional Practitioners |
| Results and Impact | Dr Louise Jones; MRC Head of Translational Research gave a presentation on the Translational funding streams offered by the MRC. Those that attended reported that not only did they learn about the many types of funding available, but that they had a better understanding of how the MRC (and advisory members) assess applications. |
| Year(s) Of Engagement Activity | 2018 |